Physician

Anil B Kumar, MD

According to 2025 Medicare claims, Anil Kumar, MD (NPI: 1073619615) practices urology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MICHIGAN UNITED PHYSICIANS PC (NPI: 1447330642; TIN: 38-3251771) and primary practice location at 48309-1481.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 699 traditional Medicare patients, billed 3,071 HCPCS/CPT codes, and received $151,238 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,027 prescription claims across 1,413 beneficiaries totaling $403,457 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 51 claims. Open Payments data shows 34 records totaling $731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $260,034 and ending at $151,238. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $195,036 to $403,457. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $758 and ending at $678.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,113	4,219	$260,034
2016	1,078	3,737	$205,166
2017	1,030	3,405	$221,276
2018	866	3,166	$210,892
2019	876	4,778	$206,789
2020	768	5,795	$196,245
2021	915	7,248	$311,069
2022	811	4,593	$224,198
2023	778	3,553	$213,046
2024	699	3,071	$151,238

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	853	3,042	$195,036
2016	825	2,834	$171,547
2017	867	2,993	$158,423
2018	899	2,874	$151,176
2019	846	2,432	$125,196
2020	889	2,860	$252,877
2021	1,122	3,792	$419,477
2022	1,183	3,966	$273,565
2023	1,206	4,121	$298,340
2024	1,413	5,027	$403,457

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	100	$12,869
2016	N/R	121	$10,670
2017	N/R	122	$11,614
2018	N/R	108	$10,939
2019	N/R	83	$16,103
2020	N/R	103	$19,866
2021	N/R	124	$16,658
2022	N/R	91	$25,987
2023	N/R	80	$25,343
2024	N/R	51	$12,630

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	339	439	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	91	106	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	143	237	$63
51798	Ultrasound measurement of bladder capacity after voiding	171	200	$8
81000	Manual urinalysis test with examination using microscope, non-automated	212	278	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	149	8,415	$120,847
Gemtesa	Vibegron	96	5,047	$79,797
Mirabegron Er	Mirabegron	44	3,570	$35,552
Orgovyx	Relugolix	13	386	$35,015
Tamsulosin Hcl	Tamsulosin Hcl	1,477	117,275	$33,721

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	34	$12,256
A4332	Lubricant, individual sterile packet, each	N	N/R	17	$374

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$731	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anil B. Kumar, MD?

Tedicare shows public-source Medicare data for Anil B. Kumar, MD (NPI 1073619615), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anil B. Kumar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anil B. Kumar, MD?

Anil B. Kumar, MD is linked to MICHIGAN UNITED PHYSICIANS PC (billing NPI 1447330642) in the available physician profile data.

Does Anil B. Kumar, MD have Open Payments data?

Anil B. Kumar, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.